Group One Trading’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Group One Trading’s Portfolio GNMX Stock Details GNMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,300	Closed	-$4K	–	5679
2018 Q4	$4K	Buy	5,300 +300	+6%	+$335	﹤0.01%	4554
2018 Q3	$6K	Hold	5,000	–	–	﹤0.01%	4804
2018 Q2	$6K	Buy	+5,000	New	+$7.6K	﹤0.01%	4791
2017 Q3	–	Sell	-10,100	Closed	-$13K	–	5381
2017 Q2	$13K	Sell	10,100 -43,400	-81%	-$62.7K	﹤0.01%	4122
2017 Q1	$100K	Sell	53,500 -44,400	-45%	-$201K	﹤0.01%	2988
2016 Q4	$507K	Buy	97,900 +83,200	+566%	+$438K	﹤0.01%	1764
2016 Q3	$82K	Sell	14,700 -2,700	-16%	-$15.4K	﹤0.01%	3064
2016 Q2	$97K	Buy	+17,400	New	+$91.4K	﹤0.01%	2887

Group One Trading's GNMX Position: Q1 2020 in Review

Group One Trading sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 1,758 shares.

Group One Trading first reported a position in GNMX in Q4 2016 and held it in 10 quarters. The position peaked at $53K in Q4 2016. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

Group One Trading reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
Group One Trading sold 1,758 Aevi Genomic Medicine Inc shares in Q1 2020.
Group One Trading first reported a position in Aevi Genomic Medicine Inc in Q4 2016 and held it in 10 quarters.
Group One Trading's Aevi Genomic Medicine Inc position peaked at $53K in Q4 2016.
2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on Group One Trading's 13F filing for Q1 2020, filed 13 May 2020.